ClinicalTrials.gov
ClinicalTrials.gov Menu

Parkdale Infant Nutrition Security Targeted Evaluation Project: Chart Review (PINSTEP-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03372408
Recruitment Status : Active, not recruiting
First Posted : December 13, 2017
Last Update Posted : July 9, 2018
Sponsor:
Information provided by (Responsible Party):
Daniel Sellen, University of Toronto

Brief Summary:

In Toronto Ontario, the Parkdale Community Health Centre operates a community outreach program entitled Parkdale Parents' Primary Prevention Project (5P's). The 5P's provides weekly pre- and post-natal support and education programs for clients. This includes an infant feeding program for mothers with infants 0-6 months (Feeding Tiny Souls). The 5P's has a diverse client-base; the program is aimed at women who are in challenging life circumstances, therefore, clients may include low-income or single mothers and newcomers to Canada.

It is important to know who is accessing community programs and what the drivers of program utilization are in order to better support the women who are enrolled and to target those who are not. The aim of this project is twofold: 1) to investigate what socio-demographic and psychosocial characteristics predict level of participation in a prenatal community outreach program targeting vulnerable mothers and 2) based on utilization of a prenatal program, are there differences in the use of a postnatal program? This study will be conducted through a retrospective chart review. The study population will consist of women who enrolled in 5P's prenatally. The hypothesis is that more vulnerable women will not attend programming as frequently.


Condition or disease Intervention/treatment
Prenatal Community Program Vulnerable Population Postnatal Community Program Other: Chart review

Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Parkdale Infant Nutrition Security Targeted Evaluation Project (PINSTEP): Formative Research (Objective 1-Retrospective Chart Review)
Actual Study Start Date : June 4, 2018
Estimated Primary Completion Date : September 30, 2018
Estimated Study Completion Date : September 30, 2018

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Program Clients
Parkdale Parents' Primary Prevention Project (5P's) clients
Other: Chart review
Retrospective chart review of program participation and socio-demographic & psychosocial characteristics




Primary Outcome Measures :
  1. Level of program participation as assessed by review of client records and program attendance records [ Time Frame: Registration to prenatal program until 12 months postpartum ]
    Retrospective chart review of client program records and attendance



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Sampling Method:   Non-Probability Sample
Study Population
Clients enrolled in Parkdale Parents' Primary Prevention Project (5P's) in Toronto, Ontario, Canada.
Criteria

Inclusion Criteria:

  • Enrolled in Parkdale Parents' Primary Prevention Project (5P's) prenatally
  • 5P's client signed the permission to release information on the 5P's intake form

Exclusion Criteria:

  • Only attended Parkdale Parents' Primary Prevention Project (5P's) postnatally
  • 5P's client did not sign the permission to release information on the 5P's intake form

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03372408


Locations
Canada, Ontario
Parkdale Community Health Centre
Toronto, Ontario, Canada, M6R 3B2
Sponsors and Collaborators
University of Toronto
Investigators
Principal Investigator: Jane Francis, MSc University of Toronto

Responsible Party: Daniel Sellen, Professor, University of Toronto
ClinicalTrials.gov Identifier: NCT03372408     History of Changes
Other Study ID Numbers: 34482-1
First Posted: December 13, 2017    Key Record Dates
Last Update Posted: July 9, 2018
Last Verified: July 2018

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No